Medical Distribution(Outdated)
- 1368.543
- +14.760+1.09%
Marinus Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), OrthoPediatrics (KIDS) and Axsome Therapeutics (AXSM)
What 4 Analyst Ratings Have To Say About Arrowhead Pharma
B of A Securities Initiates Coverage On Arrowhead Pharma With Buy Rating, Announces Price Target of $29
HC Wainwright & Co. Reiterates Buy on Cocrystal Pharma, Maintains $12 Price Target
Cocrystal Pharma Analyst Ratings
Cocrystal Pharma's Buy Rating: Promising Antiviral Developments and Stable Financial Outlook
Buy Rating Justified by Ligand Pharma's Strategic Investments and Promising Drug Platform
Arrowhead Pharma Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: UnitedHealth (UNH), Alnylam Pharma (ALNY)
Buy Rating Affirmed for Ocuphire Pharma on Promising Clinical Advancements and Strategic Partnerships
Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Ascendis Pharma (ASND) and BioMarin Pharmaceutical (BMRN)
CGS-CIMB Adjusts Hyphens Pharma's Price Target to SG$0.32 From SG$0.34, Keeps at Add
Mizuho Maintains Buy on Terns Pharma, Lowers Price Target to $10
Terns Pharma Analyst Ratings
JPMorgan Adjusts BridgeBio Pharma Price Target to $35 From $38, Maintains Overweight Rating
Oppenheimer Maintains Perform on Enanta Pharma, Lowers Price Target to $21
Enanta Pharma Analyst Ratings
ATyr Pharma (LIFE) Gets a Hold From Oppenheimer
JMP Securities Maintains Outperform on Enanta Pharma, Lowers Price Target to $23